We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Novartis AG | NYSE:NVS | NYSE | Depository Receipt |
| Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.1011 | 0.10% | 102.7911 | 1,297 | 13:51:19 |
From May 2019 to May 2024
Bayer (BAYRY, BAYN.XE) of Germany, Reckitt Benckiser (RBGLY, RB.LN) of the U.K., Novartis (NVS, NOVN.VX) of Switzerland and Procter & Gamble (PG) of the U.S. have their eye on some over-the-counter consumer products of U.S. pharmaceuticals giant Merck & Co. (MRK), German daily Die Welt reported on its website Monday, citing unnamed business sources.
Bayer and Reckitt Benckiser each have made bids of around $14 billion, the newspaper said. The products included Dr. Scholl's foot care and Coppertone sun protection products, the newspaper said.
Newspaper website: www.welt.de
Write to Dennis Baker at dennis.baker@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Novartis Chart |
1 Month Novartis Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
